Cargando…
Activity of Drug Combinations against Mycobacterium abscessus Grown in Aerobic and Hypoxic Conditions
Infections caused by Mycobacterium abscessus (Mab), an environmental non-tuberculous mycobacterium, are difficult to eradicate from patients with pulmonary diseases such as cystic fibrosis and bronchiectasis even after years of antibiotic treatments. In these people, the low oxygen pressure in mucus...
Autores principales: | Lanni, Alessio, Borroni, Emanuele, Iacobino, Angelo, Russo, Cristina, Gentile, Leonarda, Fattorini, Lanfranco, Giannoni, Federico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316547/ https://www.ncbi.nlm.nih.gov/pubmed/35889140 http://dx.doi.org/10.3390/microorganisms10071421 |
Ejemplares similares
-
Eradication of Drug-Tolerant Mycobacterium tuberculosis 2022: Where We Stand
por: Lanni, Alessio, et al.
Publicado: (2023) -
Moxifloxacin Activates the SOS Response in Mycobacterium tuberculosis in a Dose- and Time-Dependent Manner
por: Iacobino, Angelo, et al.
Publicado: (2021) -
Treating Primary Arthroprosthesis Infection Caused by Mycobacterium abscessus subsp. abscessus
por: Pace, Valerio, et al.
Publicado: (2019) -
The Antimalarial Mefloquine Shows Activity against Mycobacterium abscessus, Inhibiting Mycolic Acid Metabolism
por: Degiacomi, Giulia, et al.
Publicado: (2021) -
Conditional Gene Expression in Mycobacterium abscessus
por: Cortes, Mélanie, et al.
Publicado: (2011)